{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T05:34:51Z","timestamp":1792128891882,"version":"4.4.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-025-06179-y","type":"journal-article","created":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T19:18:26Z","timestamp":1768159106000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Real-world outcomes of bladder-sparing strategies for BCG-unresponsive non-muscle-invasive bladder cancer: a multicenter study"],"prefix":"10.1007","volume":"44","author":[{"given":"Pietro","family":"Scilipoti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Zaurito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattia","family":"Longoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Tremolada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cosenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"\u015alusarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre Etienne","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Dutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Katzendorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Krajewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Laukhtina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Oberneder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis Rodr\u00edguez","family":"Elena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso Lafuente","family":"Puentedura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge Ca\u00f1o","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Contieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodolfo","family":"Hurle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Daniel","family":"Subiela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautier","family":"Marcq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksandra","family":"Szostek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Mastroianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renate","family":"Pichler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"\u00c1lvarez-Maestro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo Aguilera","family":"Baz\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Klatte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albane Massiet","family":"du Biest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Ferrando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Buisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Villares","family":"L\u00f3pez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Zazzara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Mario","family":"Ludovico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Carando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Radziszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Soria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Pradere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"D\u2019Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahrokh F.","family":"Shariat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Montorsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Salonia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Briganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Gontero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evanguelos","family":"Xylinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Moschini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"European Association of Urology -Young Academic Urologists (EAU-YAU)","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Urothelial carcinoma working group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"the EuroGemDoce Study Group Collaborators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,11]]},"reference":[{"issue":"6","key":"6179_CR1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.eururo.2024.07.027","volume":"86","author":"P Gontero","year":"2024","unstructured":"Gontero P, Birtle A, Capoun O et al (2024) European Association of Urology guidelines on non-muscle-invasive bladder cancer (TaT1 and carcinoma in situ)-a summary of the 2024 guidelines update. Eur Urol 86(6):531\u2013549. https:\/\/doi.org\/10.1016\/j.eururo.2024.07.027","journal-title":"Eur Urol"},{"key":"6179_CR2","doi-asserted-by":"publisher","DOI":"10.1016\/j.euf.2025.04.033","author":"P Scilipoti","year":"2025","unstructured":"Scilipoti P, Longoni M, de Angelis M et al (2025) Long-term oncological outcomes for patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Gu\u00e9rin (BCG): a comparative analysis of adequate versus inadequate BCG treatment. Eur Urol Focus. https:\/\/doi.org\/10.1016\/j.euf.2025.04.033","journal-title":"Eur Urol Focus"},{"key":"6179_CR3","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16780","author":"M Longoni","year":"2025","unstructured":"Longoni M, Scilipoti P, De Angelis M et al (2025) Contemporary outcomes in non-muscle-invasive bladder cancer: a large European multicentre study. BJU Int. https:\/\/doi.org\/10.1111\/bju.16780","journal-title":"BJU Int"},{"issue":"1","key":"6179_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1111\/bju.16675","volume":"136","author":"P Scilipoti","year":"2025","unstructured":"Scilipoti P, Longoni M, de Angelis M et al (2025) Outcomes of <scp>BCG<\/scp> vs upfront radical cystectomy for high\u2010risk non\u2010muscle\u2010invasive bladder cancer. BJU Int 136(1):47\u201354. https:\/\/doi.org\/10.1111\/bju.16675","journal-title":"BJU Int"},{"issue":"1","key":"6179_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-024-04970-x","volume":"42","author":"F Pellegrino","year":"2024","unstructured":"Pellegrino F, Leni R, Basile G et al (2024) Peri- and post-operative outcomes of robot-assisted radical cystectomy after the implementation of the EAU guidelines recommendations for collecting and reporting complications at a high-volume referral center. World J Urol 42(1):270. https:\/\/doi.org\/10.1007\/s00345-024-04970-x","journal-title":"World J Urol"},{"issue":"6","key":"6179_CR6","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.eururo.2024.08.001","volume":"86","author":"R Li","year":"2024","unstructured":"Li R, Hensley PJ, Gupta S et al (2024) Bladder-sparing therapy for Bacillus Calmette-Gu\u00e9rin-unresponsive non-muscle-invasive bladder cancer: International Bladder Cancer Group recommendations for optimal sequencing and patient selection. Eur Urol 86(6):516\u2013527. https:\/\/doi.org\/10.1016\/j.eururo.2024.08.001","journal-title":"Eur Urol"},{"issue":"5","key":"6179_CR7","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1097\/JU.0000000000000688","volume":"203","author":"RL Steinberg","year":"2020","unstructured":"Steinberg RL, Thomas LJ, Brooks N et al (2020) Multi-institution evaluation of sequential gemcitabine and docetaxel as rescue therapy for nonmuscle invasive bladder cancer. J Urol 203(5):902\u2013909. https:\/\/doi.org\/10.1097\/JU.0000000000000688","journal-title":"J Urol"},{"issue":"6","key":"6179_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1111\/bju.16645","volume":"135","author":"P Scilipoti","year":"2025","unstructured":"Scilipoti P, Longoni M, de Angelis M et al (2025) Gemcitabine and docetaxel for high-risk non-muscle-invasive bladder cancer: EuroGemDoce group results. BJU Int 135(6):969\u2013976. https:\/\/doi.org\/10.1111\/bju.16645","journal-title":"BJU Int"},{"issue":"1","key":"6179_CR9","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1159\/000520630","volume":"107","author":"M Zazzara","year":"2023","unstructured":"Zazzara M, Nazaraj A, Scarcia M, Cardo G, Carando R, Ludovico GM (2023) Electromotive drug administration of mitomycin C (EMDA\/MMC) versus intravesical immunotherapy with Bacillus Calmette-Gu\u00e9rin (BCG) in intermediate and high risk non muscle invasive bladder cancer. Urol Int 107(1):64\u201371. https:\/\/doi.org\/10.1159\/000520630","journal-title":"Urol Int"},{"issue":"1","key":"6179_CR10","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-018-5134-7","volume":"18","author":"M Racioppi","year":"2018","unstructured":"Racioppi M, Di Gianfrancesco L, Ragonese M, Palermo G, Sacco E, Bassi PF (2018) ElectroMotive drug administration (EMDA) of Mitomycin C as first-line salvage therapy in high risk \u201cBCG failure\u201d non muscle invasive bladder cancer: 3\u2009years follow-up outcomes. BMC Cancer 18(1):1224. https:\/\/doi.org\/10.1186\/s12885-018-5134-7","journal-title":"BMC Cancer"},{"issue":"2","key":"6179_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/j.euo.2024.12.005","volume":"8","author":"J Taylor","year":"2025","unstructured":"Taylor J, Kamat AM, Annapureddy D et al (2025) Oncologic outcomes of sequential intravesical gemcitabine and docetaxel compared with Bacillus Calmette-Gu\u00e9rin in patients with Bacillus Calmette-Gu\u00e9rin-unresponsive non-muscle invasive bladder cancer. Eur Urol Oncol 8(2):469\u2013476. https:\/\/doi.org\/10.1016\/j.euo.2024.12.005","journal-title":"Eur Urol Oncol"},{"issue":"5","key":"6179_CR12","doi-asserted-by":"publisher","first-page":"335","DOI":"10.7326\/M18-2782","volume":"170","author":"HB Bentzen","year":"2019","unstructured":"Bentzen HB, H\u00f8stm\u00e6lingen N (2019) Balancing protection and free movement of personal data: the new European Union General Data Protection Regulation. Ann Intern Med 170(5):335\u2013337. https:\/\/doi.org\/10.7326\/M18-2782","journal-title":"Ann Intern Med"},{"issue":"4","key":"6179_CR13","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrurol.2017.16","volume":"14","author":"AM Kamat","year":"2017","unstructured":"Kamat AM, Colombel M, Sundi D et al (2017) BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG. Nat Rev Urol 14(4):244\u2013255. https:\/\/doi.org\/10.1038\/nrurol.2017.16","journal-title":"Nat Rev Urol"},{"issue":"3","key":"6179_CR14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1159\/000502663","volume":"103","author":"R Carando","year":"2019","unstructured":"Carando R, Zazzara M, Cotrufo S, Ludovico GM (2019) Intravesical treatment with electro-mediated administration of mytomicin C as prophylaxis for intermediate and high-risk nonmuscle-invasive bladder cancer: a retrospective multicenter study [published correction appears in Urol Int. 2021;105(11-12):1128. doi:10.1159\/000519186.]. Urol Int 103(3):285\u2013290. https:\/\/doi.org\/10.1159\/000502663","journal-title":"Urol Int"},{"issue":"2","key":"6179_CR15","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.eururo.2014.06.024","volume":"67","author":"AJ Vickers","year":"2015","unstructured":"Vickers AJ, Sjoberg DD, European Urology (2015) Guidelines for reporting of statistics in European urology. Eur Urol 67(2):181\u2013187. https:\/\/doi.org\/10.1016\/j.eururo.2014.06.024","journal-title":"Eur Urol"},{"issue":"3","key":"6179_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.suronc.2016.05.027","volume":"25","author":"LS Yang","year":"2016","unstructured":"Yang LS, Shan BL, Shan LL et al (2016) A systematic review and meta-analysis of quality of life outcomes after radical cystectomy for bladder cancer. Surg Oncol 25(3):281\u2013297. https:\/\/doi.org\/10.1016\/j.suronc.2016.05.027","journal-title":"Surg Oncol"},{"key":"6179_CR17","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.2309","volume":"4","author":"B Kos","year":"2016","unstructured":"Kos B, V\u00e1squez JL, Miklav\u010di\u010d D, Hermann GG, Gehl J (2016) Investigation of the mechanisms of action behind Electromotive Drug Administration (EMDA). PeerJ 4:e2309. https:\/\/doi.org\/10.7717\/peerj.2309","journal-title":"PeerJ"},{"issue":"3","key":"6179_CR18","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1097\/01.ju.0000080568.91703.18","volume":"170","author":"SM Di Stasi","year":"2003","unstructured":"Di Stasi SM, Giannantoni A, Stephen RL et al (2003) Intravesical electromotive mitomycin C versus passive transport mitomycin C for high risk superficial bladder cancer: a prospective randomized study. J Urol 170(3):777\u2013782. https:\/\/doi.org\/10.1097\/01.ju.0000080568.91703.18","journal-title":"J Urol"},{"issue":"2 Suppl 5","key":"6179_CR19","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1053\/j.seminoncol.2004.03.021","volume":"31","author":"BW Robinson","year":"2004","unstructured":"Robinson BW, Ostruszka L, Im MM, Shewach DS (2004) Promising combination therapies with gemcitabine. Semin Oncol 31(2 Suppl 5):2\u201312. https:\/\/doi.org\/10.1053\/j.seminoncol.2004.03.021","journal-title":"Semin Oncol"},{"key":"6179_CR20","doi-asserted-by":"publisher","unstructured":"Holzbeierlein JM, Bixler BR, Buckley DI, et al. Diagnosis and Treatment of Non-Muscle Invasive Bladder Cancer: AUA\/SUO Guideline: 2024 Amendment [published correction appears in J Urol. 2024;212(6):936. https:\/\/doi.org\/10.1097\/JU.0000000000004251].\u00a0J Urol. 2024;211(4):533\u2013538. https:\/\/doi.org\/10.1097\/JU.0000000000003846","DOI":"10.1097\/JU.0000000000004251"},{"issue":"4","key":"6179_CR21","doi-asserted-by":"publisher","first-page":"216","DOI":"10.6004\/jnccn.2024.0024","volume":"22","author":"TW Flaig","year":"2024","unstructured":"Flaig TW, Spiess PE, Abern M et al (2024) NCCN Guidelines\u00ae insights: bladder cancer, Version 3.2024. J Natl Compr Canc Netw 22(4):216\u2013225. https:\/\/doi.org\/10.6004\/jnccn.2024.0024","journal-title":"J Natl Compr Canc Netw"},{"issue":"2","key":"6179_CR22","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/bju.16509","volume":"135","author":"JI Taylor","year":"2025","unstructured":"Taylor JI, Kamat AM, O\u2019Donnell MA et al (2025) Long-term outcomes of bladder-sparing therapy vs radical cystectomy in BCG-unresponsive non-muscle-invasive bladder cancer. BJU Int 135(2):260\u2013268. https:\/\/doi.org\/10.1111\/bju.16509","journal-title":"BJU Int"},{"issue":"6","key":"6179_CR23","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1016\/S1470-2045(24)00178-5","volume":"25","author":"A Necchi","year":"2024","unstructured":"Necchi A, Roumigui\u00e9 M, Kamat AM et al (2024) Pembrolizumab monotherapy for high-risk non-muscle-invasive bladder cancer without carcinoma in situ and unresponsive to BCG (KEYNOTE-057): a single-arm, multicentre, phase 2 trial. Lancet Oncol 25(6):720\u2013730. https:\/\/doi.org\/10.1016\/S1470-2045(24)00178-5","journal-title":"Lancet Oncol"},{"issue":"1","key":"6179_CR24","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/JU.0000000000004020","volume":"212","author":"VM Narayan","year":"2024","unstructured":"Narayan VM, Boorjian SA, Alemozaffar M et al (2024) Efficacy of intravesical nadofaragene firadenovec for patients with Bacillus Calmette-Gu\u00e9rin-unresponsive nonmuscle-invasive bladder cancer: 5-year follow-up from a phase 3 trial. J Urol 212(1):74\u201386. https:\/\/doi.org\/10.1097\/JU.0000000000004020","journal-title":"J Urol"},{"issue":"1","key":"6179_CR25","doi-asserted-by":"publisher","DOI":"10.1056\/EVIDoa2200167","volume":"2","author":"K Chamie","year":"2023","unstructured":"Chamie K, Chang SS, Kramolowsky E et al (2023) IL-15 superagonist NAI in BCG-Unresponsive Non-Muscle-Invasive\u00a0Bladder Cancer. NEJM Evid 2(1):EVIDoa2200167. https:\/\/doi.org\/10.1056\/EVIDoa2200167","journal-title":"NEJM Evid"},{"issue":"33","key":"6179_CR26","doi-asserted-by":"publisher","first-page":"3578","DOI":"10.1200\/JCO-25-01651","volume":"43","author":"S Daneshmand","year":"2025","unstructured":"Daneshmand S, Van der Heijden MS, Jacob JM et al (2025) TAR-200 for Bacillus Calmette-Gu\u00e9rin-unresponsive high-risk non-muscle-invasive bladder cancer: results from the phase IIb sunrise-1 study. J Clin Oncol 43(33):3578\u20133588. https:\/\/doi.org\/10.1200\/JCO-25-01651","journal-title":"J Clin Oncol"},{"issue":"5","key":"6179_CR27","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.eururo.2024.12.002","volume":"87","author":"P Scilipoti","year":"2025","unstructured":"Scilipoti P, Moschini M, Li R et al (2025) The financial burden of localized and metastatic bladder cancer. Eur Urol 87(5):536\u2013550. https:\/\/doi.org\/10.1016\/j.eururo.2024.12.002","journal-title":"Eur Urol"},{"key":"6179_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.euo.2025.03.007","author":"M Longoni","year":"2025","unstructured":"Longoni M, Scilipoti P, Soria F et al (2025) Oncological outcomes in Bacillus Calmette-Gu\u00e9rin-na\u00efve high-risk non-muscle-invasive bladder cancer patients: a systematic review on current treatment strategies and future perspectives. Eur Urol Oncol. https:\/\/doi.org\/10.1016\/j.euo.2025.03.007","journal-title":"Eur Urol Oncol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06179-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-025-06179-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-025-06179-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T10:41:02Z","timestamp":1768473662000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-025-06179-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,11]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6179"],"URL":"https:\/\/doi.org\/10.1007\/s00345-025-06179-y","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,11]]},"assertion":[{"value":"21 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"82"}}